Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
EchoIQ Limited ( (AU:EIQ) ) has provided an update.
Echo IQ has completed its presentation to the CPT Editorial Panel regarding its application for a Category III CPT code for EchoSolv AS in the US. While awaiting the panel’s decision, the company continues to focus on deploying EchoSolv AS in the US and progressing FDA clearance for EchoSolv HF, alongside new product development and partnership opportunities, which are advancing as planned.
The most recent analyst rating on (AU:EIQ) stock is a Buy with a A$0.40 price target. To see the full list of analyst forecasts on EchoIQ Limited stock, see the AU:EIQ Stock Forecast page.
More about EchoIQ Limited
Echo IQ is an AI-driven medical technology company based in Sydney, Australia, specializing in proprietary software to enhance decision-making in cardiology.
Average Trading Volume: 1,121,678
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$161.9M
See more insights into EIQ stock on TipRanks’ Stock Analysis page.